Base case model effectiveness and epidemiological data with sensitivity analysis ranges used in the cost-effectiveness analyses of 23-valent polysaccharide pneumococcal vaccine (PPV23) for persons aged 60 years in Brazil.

IPD—Invasive pneumococcal diseaseB95.3—Streptococcus pneumoniae as the cause of disease classified elsewhere*These rates were converted to transition probabilities with the formula: p = 1 –exp(-rt). Where p is the transition probability, r is the rate, and t is time.Base case model effectiveness and epidemiological data with sensitivity analysis ranges used in the cost-effectiveness analyses of 23-valent polysaccharide pneumococcal vaccine (PPV23) for persons aged 60 years in Brazil.